Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V8WE
|
||||
Former ID |
DNC014086
|
||||
Drug Name |
4-(4,5-dihydrothiazol-2-yl)phenyl butylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529975] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H18N2O2S
|
||||
Canonical SMILES |
CCCCNC(=O)OC1=CC=C(C=C1)C2=NCCS2
|
||||
InChI |
1S/C14H18N2O2S/c1-2-3-8-16-14(17)18-12-6-4-11(5-7-12)13-15-9-10-19-13/h4-7H,2-3,8-10H2,1H3,(H,16,17)
|
||||
InChIKey |
OUBMDYCXTDANEM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529975] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.